⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1224449 | 0.95 | — | — | |
| SCHEMBL10398333 | 0.90 | — | — | |
| SCHEMBL17138356 | 0.70 | — | — | |
| SCHEMBL17138289 | 0.70 | — | — | |
| SCHEMBL12000716 | 0.70 | — | — | |
| SCHEMBL9007252 | 0.69 | — | — | |
| SCHEMBL8207543 | 0.67 | — | — | |
| SCHEMBL125830 | 0.67 | — | — | |
| SCHEMBL1262675 | 0.67 | — | — | |
| SCHEMBL10794391 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115746053-A | Si-PCCP ligand, preparation method thereof, ethylene oligomerization catalyst and application thereof | 万华化学集团股份有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-117050214-A | Method for producing fluorinated solid oxides and use thereof in metallocene-based catalyst systems | 切弗朗菲利浦化学公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-112672821-B | Method for producing fluorinated solid oxides and use thereof in metallocene-based catalyst systems | 切弗朗菲利浦化学公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-115746053-A | Si-PCCP ligand, preparation method thereof, ethylene oligomerization catalyst and application thereof | 万华化学集团股份有限公司 | 2023-03-07 | — | — | CN | disclosed |
| EP-2429993-B1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INT (DE) | 2015-01-21 | — | — | EP | disclosed |
| US-8841331-B2 | Inhibitors of human immunodeficiency virus replication | GILEAD SCIENCES, INC. (US) | 2014-09-23 | — | — | US | disclosed |
| US-20130203747-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | GILEAD SCIENCES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-8338441-B2 | Inhibitors of human immunodeficiency virus replication | GILEAD SCIENCES, INC. (US) | 2012-12-25 | — | — | US | disclosed |
| EP-2429993-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | Gilead Sciences, Inc. (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20100292227-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | US | disclosed |
| WO-2004074333-A2 | PROCESS FOR HOMO- OR COPOLYMERIZATIONOF CONJUGATED OLEFINES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2004-09-02 | — | — | WO | disclosed |
| EP-1394162-A1 | Intermediates of azole antifungal agents and processes for the preparation thereof | Eisai Co., Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
| EP-1394142-A1 | Carboxylic acid intermediates of antifungal agents and processes for the preparation thereof | Eisai Co., Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
| EP-1231210-A2 | Azole antifungal agents, processes for the preparation thereof, and intermediates | Eisai Co., Ltd. (JP) | 2002-08-14 | — | — | EP | disclosed |
| US-5792781-A | EFFECTIVE AGAINST DERMATOMYCOSIS/VISCEROMYCOSIS CAUSED BY FUNGI, I.E., CANDIDA ALBICANS | EISAI CO., LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| US-5789429-A | FUNGICIDE | EISAI CO., LTD. (JP) | 1998-08-04 | — | — | US | disclosed |
| US-5648372-A | TRIAZOLES | EISAI CO., LTD. (JP) | 1997-07-15 | — | — | US | disclosed |
| EP-0667346-A2 | Azole antifungal agents, process for the preparation there of and intermediates | Eisai Co., Ltd. (JP) | 1995-08-16 | — | — | EP | disclosed |
| US-5164524-A | Process for preparing tetra (organyl) telluride compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1992-11-17 | — | — | US | disclosed |
| US-5157154-A | Tetra (organyl) tellurium compounds and process for preparing same | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1992-10-20 | — | — | US | disclosed |